
("Catenai" or the "Company")
Launch of Alludium at LangChain's
Alludium is a company in which Catenai has entered into a subscription agreement to acquire an initial shareholding of approximately 8% as announced on
Interrupt is the gathering for anyone passionate about the future of agentic AI. Consisting of hands-on workshops, live demos, and talks from industry luminaries like
The person who arranged for release of this announcement on behalf of the Company was
For further information please contact:
|
+44 (0)20 7183 8666 |
|
|
|
|
|
+44(0)20 7213 0880 |
|
|
|
|
|
+44 (0)20 7186 9952 |
|
|
|
|
Notes to Editors:
About
Catenai is an AIM quoted provider of digital media and technology services. The Company specialises in IT solutions that solve commercial challenges and create opportunities for its clients, with an increasing focus on incorporating AI into their platforms. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the